Multiple sclerosis - Side effects of interferon beta therapy and their management

被引:240
作者
Walther, EU
Hohlfeld, R
机构
[1] Univ Munich, Dept Neurol, D-8000 Munich, Germany
[2] Inst Clin Neuroimmunol, Munich, Germany
关键词
MS; interferon beta; therapy; side effects;
D O I
10.1212/WNL.53.8.1622
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Interferon beta (IFN beta) reduces the relapse rate, disease activity as measured by serial MRI scanning, and disease progression of MS. Therapy with IFN beta may be associated with a number of adverse reactions. Relatively frequent side effects include flu-like symptoms, transient laboratory abnormalities, menstrual disorders, and increased spasticity. Dermal injection site reactions occur after subcutaneous application of IFN beta-1 beta and IFN beta-1a. Possible side effects of IFN beta include various autoimmune reactions, capillary leak syndrome, anaphylactic shock, thrombotic-thrombocytopenic purpura, insomnia, headache, alopecia, and depression. We discuss the mechanisms and management of the different side effects of IFN beta.
引用
收藏
页码:1622 / 1627
页数:6
相关论文
共 72 条
[1]  
Alsalameh S, 1998, ARTHRITIS RHEUM, V41, P754, DOI 10.1002/1529-0131(199804)41:4<754::AID-ART33>3.0.CO
[2]  
2-K
[3]   INTERFERONS AND MULTIPLE-SCLEROSIS [J].
ARNASON, BGW ;
REDER, AT .
CLINICAL NEUROPHARMACOLOGY, 1994, 17 (06) :495-547
[4]   Onset of myasthenia gravis in a patient with multiple sclerosis during interferon-1b treatment [J].
Blake, G ;
Murphy, S .
NEUROLOGY, 1997, 49 (06) :1747-1748
[5]   Emotional state of patients with relapsing-remitting MS treated with interferon beta-1b [J].
Borràs, C ;
Río, J ;
Porcel, J ;
Barrios, M ;
Tintoré, M ;
Montalban, X .
NEUROLOGY, 1999, 52 (08) :1636-1639
[6]   Enhanced spasticity in primary progressive MS patients treated with interferon beta-1b [J].
Bramanti, P ;
Sessa, E ;
Rifici, C ;
D'Aleo, G ;
Floridia, D ;
Di Bella, P ;
Lublin, F .
NEUROLOGY, 1998, 51 (06) :1720-1723
[7]   Interferon-beta(1b) treatment decreases tumor necrosis factor-alpha and increases interleukin-6 production in multiple sclerosis [J].
Brod, SA ;
Marshall, GD ;
Henninger, EM ;
Sriram, S ;
Khan, M ;
Wolinsky, JS .
NEUROLOGY, 1996, 46 (06) :1633-1638
[8]  
CIRELLI R, 1997, INTERFERON THERAPY M, P445
[9]   Anaphylactoid reaction to methyl prednisolone developing after starting treatment with interferon β-1b [J].
Clear, D .
JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY, 1999, 66 (05) :690-690
[10]  
Colosimo C, 1997, ACTA NEUROL SCAND, V96, P372